MLex Comment: J&J may seek EC scrutiny for rumoured Synthes purchase
US healthcare group Johnson & Johnson’s rumoured acquisition of Swiss medical-device maker Synthes would be likely to require European Commission merger-control approval, given their respective revenues in Europe. Regulatory scrutiny may...To view the full article, register now.
Already a subscriber? Click here to view full article